ENVVENO MEDICAL (Germany) Performance

5HJ Stock   2.56  0.02  0.78%   
The firm shows a Beta (market volatility) of -0.0051, which means not very significant fluctuations relative to the market. As returns on the market increase, returns on owning ENVVENO MEDICAL are expected to decrease at a much lower rate. During the bear market, ENVVENO MEDICAL is likely to outperform the market. ENVVENO MEDICAL DL currently shows a risk of 4.96%. Please confirm ENVVENO MEDICAL DL total risk alpha, maximum drawdown, skewness, as well as the relationship between the treynor ratio and potential upside , to decide if ENVVENO MEDICAL DL will be following its price patterns.

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Over the last 90 days ENVVENO MEDICAL DL 00001 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, ENVVENO MEDICAL is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
  

ENVVENO MEDICAL Relative Risk vs. Return Landscape

If you would invest  268.00  in ENVVENO MEDICAL DL 00001 on December 17, 2024 and sell it today you would lose (12.00) from holding ENVVENO MEDICAL DL 00001 or give up 4.48% of portfolio value over 90 days. ENVVENO MEDICAL DL 00001 is currently producing 0.0399% returns and takes up 4.9639% volatility of returns over 90 trading days. Put another way, 44% of traded stocks are less volatile than ENVVENO, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon ENVVENO MEDICAL is expected to generate 5.51 times more return on investment than the market. However, the company is 5.51 times more volatile than its market benchmark. It trades about 0.01 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly -0.08 per unit of risk.

ENVVENO MEDICAL Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for ENVVENO MEDICAL's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ENVVENO MEDICAL DL 00001, and traders can use it to determine the average amount a ENVVENO MEDICAL's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.008

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns5HJ

Estimated Market Risk

 4.96
  actual daily
44
56% of assets are more volatile

Expected Return

 0.04
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 0.01
  actual daily
0
Most of other assets perform better
Based on monthly moving average ENVVENO MEDICAL is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ENVVENO MEDICAL by adding ENVVENO MEDICAL to a well-diversified portfolio.

Things to note about ENVVENO MEDICAL DL performance evaluation

Checking the ongoing alerts about ENVVENO MEDICAL for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ENVVENO MEDICAL DL help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
ENVVENO MEDICAL DL had very high historical volatility over the last 90 days
Evaluating ENVVENO MEDICAL's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate ENVVENO MEDICAL's stock performance include:
  • Analyzing ENVVENO MEDICAL's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ENVVENO MEDICAL's stock is overvalued or undervalued compared to its peers.
  • Examining ENVVENO MEDICAL's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating ENVVENO MEDICAL's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ENVVENO MEDICAL's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of ENVVENO MEDICAL's stock. These opinions can provide insight into ENVVENO MEDICAL's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating ENVVENO MEDICAL's stock performance is not an exact science, and many factors can impact ENVVENO MEDICAL's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for ENVVENO Stock analysis

When running ENVVENO MEDICAL's price analysis, check to measure ENVVENO MEDICAL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ENVVENO MEDICAL is operating at the current time. Most of ENVVENO MEDICAL's value examination focuses on studying past and present price action to predict the probability of ENVVENO MEDICAL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ENVVENO MEDICAL's price. Additionally, you may evaluate how the addition of ENVVENO MEDICAL to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
CEOs Directory
Screen CEOs from public companies around the world